PIVOTAL BIOVENTURE PARTNERS FUND I, L.P. purchased 112.9% of their position (833.33K shares) of INOZYME PHARMA, INC. on the open market
Open‑market purchase worth $4.00M — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/3/2023ACC: 0000950170-23-038272
10% Owner
Since Jul 2020
+833.33K
Net shares
Net buyer
$4.00M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
833.33K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+119.05K
Price / share
$4.80
Trade value
$571.43K
% of position
4.2%
8/1/2023
2.80M→2.92M
Common Stock
Indirect
Shares
+714.28K
Price / share
$4.80
Trade value
$3.43M
% of position
83.3%
8/1/2023
857.46K→1.57M
Total
Net shares
+833.33K
Net value
$4M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/1/2023 | P · Purchase | +119.05K | $4.80 | $571.43K | 4.2% | 2.80M | 2.92M |
| Common Stock Indirect | 8/1/2023 | P · Purchase | +714.28K | $4.80 | $3.43M | 83.3% | 857.46K | 1.57M |
| Total | +833.33K | $4M | ||||||
Derivative Transactions0
No derivative transactions reported